Key Drivers
- Margin Expansion
- Liquidity Strength
- Receivables Risk
AIAI Summary
NUTX's investment case has shifted to proving that its exceptional June-quarter margins and cash flow are sustainable despite declining revenue and receivables equal to roughly 1.7x quarterly sales; investors should await evidence of revenue stabilization and collections quality before treating its low valuation as a durable bargain.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Margin Expansion
- •Liquidity Strength
- •Receivables Risk
NUTX shows sharply improved quarterly profitability, liquidity, and leverage with lower valuation multiples, though high receivables, non-controlling interests, and negative retained earnings warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Strong Recent Rally
- •Resistance Rejection
- •Pullback Risk
NUTX remains bullish over the last month but faces active $217–$218 resistance, with a pullback risking a retest of $200–$197 support.
Sharp rally from roughly $191 to $217 followed by a quick pullback
Sentiment & News
Key News Insights:
- •Analyst Upside
- •Momentum Strength
- •Data Breach
Nutex Health shows bullish analyst and momentum signals, tempered by ongoing cybersecurity scrutiny.
Positive market sentiment may support shares, but cybersecurity developments remain a material risk
Similar Companies in Healthcare
Other companies in the same sector with AI ratings